Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee
Clinical trial NCT02139319 · COMPLETED
Trial details
- NCT number
- NCT02139319
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-07-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.